and the University of California at San Francisco will work together to develop new diagnostic tests, a collaboration that pairs an academic research organization with the world's largest diagnostic services provider. The organizations will focus on developing tests that may include the use of imaging or other technologies in workups and take into account specific biomarkers or other genetic indicators of disease, as well as clinical and population research.
The multiyear initiative will initially focus on developing new diagnostics related to the treatment of autism, cancer, neurological diseases and disorders and women's health.
Quest will pay an unspecified annual sum to support the infrastructure of the program. Also, the company will award about five to 10 individual grants of $50,000 to $500,000 to UCSF researchers each year. Follow Jaimy Lee on Twitter: @MHjlee